Sellgren, Carl M.
Imbeault, Sophie
Larsson, Markus K.
Oliveros, Alfredo
Nilsson, Ida A. K. http://orcid.org/0000-0002-7676-4299
Codeluppi, Simone
Orhan, Funda
Bhat, Maria
Tufvesson-Alm, Maximilian
Gracias, Jessica http://orcid.org/0000-0002-1730-7821
Kegel, Magdalena E.
Zheng, Yiran
Faka, Anthi
Svedberg, Marie
Powell, Susan B.
Caldwell, Sorana
Kamenski, Mary E.
Vawter, Marquis P.
Schulmann, Anton http://orcid.org/0000-0002-6323-4969
Goiny, Michel
Svensson, Camilla I.
Hökfelt, Tomas
Schalling, Martin
Schwieler, Lilly
Cervenka, Simon
Choi, Doo-Sup http://orcid.org/0000-0002-6796-9938
Landén, Mikael
Engberg, Göran http://orcid.org/0000-0003-1659-5232
Erhardt, Sophie
Funding for this research was provided by:
Vetenskapsrådet (2019-01452, 2017-02559, 2017-00875, 2009-3068, 2018-02653, 2017-00875)
Hjärnfonden
Åhlens-stiftelsen
Knut och Alice Wallenbergs Stiftelse
Karolinska Institutet
The Mayo Clinic-Karolinska Institutet Collaborative Grant Foundation The Mayo Clinic Metabolomics Core Pilot Grant
Broad Institute
Stiftelsen för Strategisk Forskning (KF10-0039)
Stockholms Läns Landsting (ALF 20170019)
Stanley Medical Research Institute
Torsten Söderbergs Stiftelse
Petrus och Augusta Hedlunds Stiftelse
The KI-AstraZeneca Joint Research Program Märta Lundqvists Stiftelse The Mayo Clinic-Karolinska Institutet Collaborative Grant Foundation The Mayo Clinic Metabolomics Core Pilot Grant
Article History
Received: 18 July 2020
Accepted: 7 April 2021
First Online: 12 May 2021
Change Date: 8 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-021-01371-z
Compliance with ethical standards
:
: MB is employed by AstraZeneca. D-SC is a scientific advisory board member to Peptron Inc. CMS is a scientific advisor to Outermost Inc. (MA, USA). All other authors declare they have no competing interests.